Skip to content

Routine Health Care of Patients With FSHD

Course and Follow up of Patients Affected by Facioscapulohumeral Muscular Dystrophy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02622438
Acronym
FSHD
Enrollment
189
Registered
2015-12-04
Start date
2015-04-19
Completion date
2024-07-03
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Disease Fascioscapulohumeral Dystrophy (FSHD)

Keywords

FSHD, Usual care performed at Montpellier hospital, Muscle function, Antioxidants, Oxidative stress, Quality of life, Physical activities, development of food-based dietary guidelines, Co-morbidity

Brief summary

On the basis of published data and our results indicating that oxidative stress may contribute to the peripheral skeletal muscle dysfunction in patients with FSHD, investigators conducted a pilot randomized double-blind placebo controlled trial to test whether oral administration of vitamins and mineral could improve the physical performance of patients with FSHD.The result of this clinical trial showed that antioxidants supplementation may improve skeletal muscle function of patients with FSHD and suggest that an antioxidant strategy adapted may be a relevant therapeutic approach for these patients. Since then, patients with FSHD who attend consultation at Montpellier hospital are systematically supplemented with antioxidants according their own blood tests.

Detailed description

This study will assess course of patients with FSHD in accordance with usual care performed within the Department of clinical physiology at the University hospital of Montpellier. This prospective longitudinal study include an initial assessment. Then the follow up of patients will be monitored at 12 months and annually. The eventual objective will be to develop a FSHD disease cohort in care at the Montpellier hospital. A statistical analysis will be performed at 3-years follow-up

Interventions

OTHERFollowed with an initial assessment, 12 months and followed annually corresponding to the usual follow-up of the patient.

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Molecular and clinical diagnosis for FSHD * patients, men and women aged \> 7 years,

Exclusion criteria

* pregnant women * Inability to understand the nature and goals of the study and / or communication difficulties with the investigator * Major protected by law (guardianship, curatorship or under judicial protection)

Design outcomes

Primary

MeasureTime frame
Effect of usual care performed at Montpellier hospital on the measurement of the maximal voluntary contraction (MVC) of quadriceps expressed in kg1 day (the day of inclusion)

Secondary

MeasureTime frame
Effect of usual care performed at Montpellier hospital on quality of life (SF36 questionnaire)1 day (the day of inclusion)
Effect of usual care performed at Montpelier hospital on physical activities (Vorrips questionnaire)1 day (the day of inclusion)
Effect of usual care performed at Montpellier hospital on physical activities (Vorrips questionnaire)12 months after inclusion
Effect of usual care performed at Montpellier hospital on oxidative stress markers measured by laboratory tests1 day (the day of inclusion)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026